---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-045871"
form_type: "8-K"
ticker: "KZR"
cik: "0001645666"
company_name: "Kezar Life Sciences, Inc."
filed_at: "2025-10-22T23:59:59+00:00"
generated_at: "2026-05-17T02:45:59.348134+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Kezar Life Sciences repays $6.3M in full, terminates Loan Agreement with Oxford Finance

## Summary
- Repaid $6.3M in full satisfaction of outstanding amount including accrued interest and exit fees.
- Loan and Security Agreement dated Nov 4, 2021 terminated; all liens and security interests released.
- Repayment made using cash on hand; no new debt incurred.

## SEC filing metadata
- accession: 0001628280-25-045871
- form_type: 8-K
- ticker: KZR
- cik: 0001645666
- company_name: Kezar Life Sciences, Inc.
- filed_at: 2025-10-22T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1645666/000162828025045871/0001628280-25-045871-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1645666/000162828025045871/kzr-20251020.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-045871
- JSON: https://secwatch.observer/filing/0001628280-25-045871.json
- Plain text: https://secwatch.observer/filing/0001628280-25-045871.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.